HANS-JÜRGEN QUABBE

Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.

Ursula Plöckinger, Martin Reichel, U. Fett et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 116 citations

Medicine, Endocrinology, Nuclear Medicine +17

Gastrointestinal Side-Effects of Octreotide during Long Term Treatment of Acromegaly*

Ursula Plöckinger, D. Dienemann, HANS-JÜRGEN QUABBE · The Journal of Clinical Endocrinology & Metabolism · 1990 · 97 citations

Medicine, Endocrinology, Internal Medicine +15

Dose-Response Study and Long Term Effect of the Somatostatin Analog Octreotide in Patients with Therapy-Resistant Acromegaly*

HANS-JÜRGEN QUABBE, Ursula Plöckinger · The Journal of Clinical Endocrinology & Metabolism · 1989 · 81 citations

Medicine, Endocrinology, Pharmacology +14

Studies on the relationship between plasma free fatty acids and growth hormone secretion in man

HANS-JÜRGEN QUABBE, H. Bratzke, Ulrike Siegers et al. · Journal of Clinical Investigation · 1972 · 80 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to octreotide therapy and do not correlate with tumor histology

Ursula Plöckinger, Michael Bäder, Werner Hopfenmüller et al. · European Journal of Endocrinology · 1997 · 63 citations

Medicine, Endocrinology, Surgery +17